Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Mobile Phone Messaging to Improve Women's and Children's Health (Mobile WACh) in Kenya (Mobile WACh)

This study has been completed.
Sponsor:
Collaborators:
National Institutes of Health (NIH)
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
University of Nairobi
Kenyatta National Hospital
Information provided by (Responsible Party):
Jennifer Unger, University of Washington
ClinicalTrials.gov Identifier:
NCT01894126
First received: July 2, 2013
Last updated: November 7, 2016
Last verified: November 2016
  Purpose
With the increased prevalence of cellular phones, mobile technology provides an important tool to reach underserved populations in low to middle income countries. mHealth interventions offer promise to improve maternal child health throughout the reproductive health continuum if they contribute to increasing skilled birth attendance, family planning and exclusive breastfeeding. We propose a randomized clinical trial to determine effect of using mobile phones to deliver SMS (one-way) versus an interactive SMS dialogue (two-way) on uptake of reproductive and neonatal health services and maternal and infant outcomes

Condition Intervention
Maternal Health
Neonatal Health
Family Planning
Behavioral: Two-way SMS Dialogue
Behavioral: One-way SMS Messaging

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Prevention
Official Title: Mobile Phone One Way Short Message Service (SMS) Versus SMS Dialogue for Women's and Child Health (Mobile WACh) in Kenya: A Randomized Control Trial

Resource links provided by NLM:


Further study details as provided by University of Washington:

Primary Outcome Measures:
  • Contraceptive uptake [ Time Frame: 10 weeks postpartum; 24 weeks postpartum ] [ Designated as safety issue: No ]
  • Facility Delivery [ Time Frame: Postpartum ] [ Designated as safety issue: No ]
  • Exclusive Breastfeeding [ Time Frame: 24 weeks postpartum ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • ANC attendance [ Time Frame: Postpartum ] [ Designated as safety issue: No ]
  • Infant Immunizations [ Time Frame: Six months postpartum ] [ Designated as safety issue: No ]
  • Maternal mortality [ Time Frame: 6 months postpartum ] [ Designated as safety issue: No ]
  • Infant mortality [ Time Frame: Six months postpartum ] [ Designated as safety issue: No ]

Enrollment: 300
Study Start Date: July 2013
Primary Completion Date: July 2015 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Two-way SMS dialogue
Women will receive SMS messages with prompts to reply. They will have the ability to text back to the system and both respond to and initiate SMS dialogue
Behavioral: Two-way SMS Dialogue
Experimental: One-way SMS Messaging
Women will receive scheduled one-way SMS messages
Behavioral: One-way SMS Messaging
No Intervention: Control

  Eligibility

Ages Eligible for Study:   14 Years and older   (Child, Adult, Senior)
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Pregnant
  • Access to a mobile phone
  • Able to read SMS messages
  • Willing to receive SMS messages

Exclusion Criteria:

  • Unwilling or unable to meet inclusion criteria
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01894126

Locations
Kenya
Mathare North Health Centre
Nairobi, Kenya
Sponsors and Collaborators
University of Washington
National Institutes of Health (NIH)
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
University of Nairobi
Kenyatta National Hospital
  More Information

Responsible Party: Jennifer Unger, Assistant Professor, University of Washington
ClinicalTrials.gov Identifier: NCT01894126     History of Changes
Other Study ID Numbers: K12HD001264-14UNGER  K12HD001264-14 
Study First Received: July 2, 2013
Last Updated: November 7, 2016
Health Authority: United States: Institutional Review Board
Kenya: Ethics Review Committee

ClinicalTrials.gov processed this record on December 02, 2016